Dr. Gary A. Buxa, MD

Dr. Buxa practices at Apogee Surgery Center in Redding, California.

Dr. Buxa's NPI, 1013991124, was assigned on December 1, 2005. Dr. Buxa graduated from University of North Dakota School of Medicine & Health Sciences in 1996. Dr. Buxa holds California license A74853.

Dr. Buxa's primary practice is Apogee Surgery Center, at 1238 West Street, Redding, CA 96001. The practice phone is (530) 241-5499. Dr. Buxa also practices at Apogee Surgery Center, 3305 Placer St, Redding, CA 96001.

Dr. Buxa's primary practice is Apogee Surgery Center in Redding, California. Dr. Buxa is also affiliated with Mercy Medical Center Redding. The medical group on file is San Francisco International Airport (SFO) Medical Clinic. Dmand AI also links Dr. Buxa to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Buxa practices, 6 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Buxa's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Buxa is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Buxa's licenses on file in 2 states: California and Texas.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment and larynx and vocal cord disease among the conditions Dr. Buxa treats.

CMS data shows 10,496 Medicare services from Dr. Buxa across 30 procedure codes in 2024, for 1,145 Medicare patients. Medicare paid $464,865 for them.

CMS counts 1,145 Medicare patients who saw Dr. Buxa in 2024. The largest group is 65 to 74, with 507 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Buxa's median patient age at 68, with 56% women.

In 2024, Dr. Buxa wrote 1,225 Medicare Part D claims for 480 patients. 95% of them were for generic drugs. CMS names the drug for 1,095 of them, across 18 drugs with 11 or more claims each, at $85,748 in total drug cost. In 2023, CMS named 949 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Buxa for performance year 2024, reported individually. Dr. Buxa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 14 procedures of melanoma (skin cancer) excision by Dr. Buxa, more than 69% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 110 general payments to Dr. Buxa from 25 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 66% of the total. Stryker Corporation paid the most, $1,547.

Dmand AI lists 3 awards for Dr. Buxa, most recently ACS Fellow in 2012.

Dr. Buxa graduated from University of North Dakota School of Medicine & Health Sciences in 1996. Dr. Buxa is a member of NHS and ACS.

Dr. Buxa is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.